Nurix

1 follower


Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Nurix is focused on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents.

Industries

Headquarters

Stage

Employees

Links

Org chart

Arthur T. Sands
President, CEO & Board Director

Arthur T. Sands

Collapse
Gwenn M. Hansen
Chief Scientific Officer
Eric Schlezinger
Chief People Officer
Christine Ring
General Counsel & Secretary
Christopher B. Phelps
SVP & Head of Early Discovery
Janine Powers
VP & Head of Translational Medicine
Seema P. Rogers
VP & Head of Clinical Operations
Raf Lambrecht
VP, Head of Regulatory
Eren Demirhan
VP & Head, Biometrics
George W. Cole
VP, Clinical Development
Elizabeth Bosch
VP, Alliance & Program Management
Paula G. O’Connor
SVP, Clinical Development
Nathalie M.e. Martineau
Director, Quality Assurance Cell Therapy
Praveen Srivastava
Senior Manager, Head Of Development Bioanalytical